William John Gradishar
AuthID: R-00F-H4W
1
TÃTULO: Margetuximab Versus Trastuzumab in Patients With Previously Treated HER2-Positive Advanced Breast Cancer (SOPHIA): Final Overall Survival Results From a Randomized Phase 3 Trial
AUTORES: Rugo, HS; Im, SA; Cardoso, F; Cortes, J; Curigliano, G; Musolino, A; Pegram, MD; Bachelot, T; Wright, GS; Saura, C; Escrivá de Romaní, S; De Laurentiis, M; Schwartz, GN; Pluard, TJ; Ricci, F; Gwin, WR; 3rd; Levy, C; Brown Glaberman, U; Ferrero, JM; ...Mais
PUBLICAÇÃO: 2023, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 41, NÚMERO: 2
AUTORES: Rugo, HS; Im, SA; Cardoso, F; Cortes, J; Curigliano, G; Musolino, A; Pegram, MD; Bachelot, T; Wright, GS; Saura, C; Escrivá de Romaní, S; De Laurentiis, M; Schwartz, GN; Pluard, TJ; Ricci, F; Gwin, WR; 3rd; Levy, C; Brown Glaberman, U; Ferrero, JM; ...Mais
PUBLICAÇÃO: 2023, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 41, NÚMERO: 2
INDEXADO EM: 
Scopus 
WOS
Scopus WOS2
TÃTULO: Phase 3 SOPHIA study of margetuximab plus chemotherapy vs trastuzumab plus chemotherapy in patients with HER2+metastatic breast cancer after prior anti-HER2 therapies: Infusion time substudy results
AUTORES: William J Gradishar; Seock Ah Im; Fatima Cardoso; Javier Cortes; Giuseppe Curigliano; Mark D Pegram; Antonino Musolino; Rosanna Berardi; Michelino De laurentiis; Shakeela W Bahadur; Young Hyuck Im; Cynthia Lynch; Yelena Novik; Sutton Edlich; Edwin Rock; Shengyan Hong; Hope S Rugo;
PUBLICAÇÃO: 2020, FONTE: San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 80, NÚMERO: 4
AUTORES: William J Gradishar; Seock Ah Im; Fatima Cardoso; Javier Cortes; Giuseppe Curigliano; Mark D Pegram; Antonino Musolino; Rosanna Berardi; Michelino De laurentiis; Shakeela W Bahadur; Young Hyuck Im; Cynthia Lynch; Yelena Novik; Sutton Edlich; Edwin Rock; Shengyan Hong; Hope S Rugo;
PUBLICAÇÃO: 2020, FONTE: San Antonio Breast Cancer Symposium in CANCER RESEARCH, VOLUME: 80, NÚMERO: 4
INDEXADO EM: WOS
WOS3
TÃTULO: SOPHIA analysis by chemotherapy (Ctx) choice: A phase III (P3) study of margetuximab (M) plus Ctx versus trastuzumab (T) plus Ctx in patients (pts) with pretreated HER2+metastatic (met) breast cancer (MBC).
AUTORES: Santiago Escriva; Seock Ah Im; Fatima Cardoso; Javier Cortes; Giuseppe Curigliano; William John Gradishar; Mark D Pegram; Gail Lynn Shaw Wright; Christelle Levy; Michelino De laurentiis; Jean Marc Ferrero; Shakeela Wazeen Bahadur; Sung Bae Kim; Katarina Petrakova; David A Riseberg; Denise A Yardley; Sutton Edlich; Sam Hong; Edwin P Rock; Hope S Rugo;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 15
AUTORES: Santiago Escriva; Seock Ah Im; Fatima Cardoso; Javier Cortes; Giuseppe Curigliano; William John Gradishar; Mark D Pegram; Gail Lynn Shaw Wright; Christelle Levy; Michelino De laurentiis; Jean Marc Ferrero; Shakeela Wazeen Bahadur; Sung Bae Kim; Katarina Petrakova; David A Riseberg; Denise A Yardley; Sutton Edlich; Sam Hong; Edwin P Rock; Hope S Rugo;
PUBLICAÇÃO: 2020, FONTE: JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 38, NÚMERO: 15
INDEXADO EM: WOS
WOS4
TÃTULO: Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology
AUTORES: William J Gradishar; Benjamin O Anderson; Jame Abraham; Rebecca Aft; Doreen Agnese; Kimberly H Allison; Sarah L Blair; Harold J Burstein; Chau Dang; Anthony D Elias; Sharon H Giordano; Matthew P Goetz; Lori J Goldstein; Steven J Isakoff; Jairam Krishnamurthy; Janice Lyons; Kelly K Marcom; Jennifer Matro; Ingrid A Mayer; Meena S Moran; ...Mais
PUBLICAÇÃO: 2020, FONTE: Journal of the National Comprehensive Cancer Network, VOLUME: 18, NÚMERO: 4
AUTORES: William J Gradishar; Benjamin O Anderson; Jame Abraham; Rebecca Aft; Doreen Agnese; Kimberly H Allison; Sarah L Blair; Harold J Burstein; Chau Dang; Anthony D Elias; Sharon H Giordano; Matthew P Goetz; Lori J Goldstein; Steven J Isakoff; Jairam Krishnamurthy; Janice Lyons; Kelly K Marcom; Jennifer Matro; Ingrid A Mayer; Meena S Moran; ...Mais
PUBLICAÇÃO: 2020, FONTE: Journal of the National Comprehensive Cancer Network, VOLUME: 18, NÚMERO: 4
5
TÃTULO: Everolimus Plus Endocrine Therapy for Postmenopausal Women With Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer A Clinical Trial
AUTORES: Melanie Royce; Thomas Bachelot; Cristian Villanueva; Mustafa Ozguroglu; Sergio J Azevedo; Felipe Melo Cruz; Marc Debled; Roberto Hegg; Tatsuya Toyama; Carla Falkson; Joon Jeong; Vichien Srimuninnimit; William J Gradishar; Christina Arce; Antonia Ridolfi; Chinjune J Lin; Fatima Cardoso;
PUBLICAÇÃO: 2018, FONTE: JAMA ONCOLOGY, VOLUME: 4, NÚMERO: 7
AUTORES: Melanie Royce; Thomas Bachelot; Cristian Villanueva; Mustafa Ozguroglu; Sergio J Azevedo; Felipe Melo Cruz; Marc Debled; Roberto Hegg; Tatsuya Toyama; Carla Falkson; Joon Jeong; Vichien Srimuninnimit; William J Gradishar; Christina Arce; Antonia Ridolfi; Chinjune J Lin; Fatima Cardoso;
PUBLICAÇÃO: 2018, FONTE: JAMA ONCOLOGY, VOLUME: 4, NÚMERO: 7
INDEXADO EM: Scopus WOS
Scopus WOS6
TÃTULO: BOLERO-4: Multicenter, open-label, phase II study of everolimus plus letrozole as first-line therapy in ER+, HER2(-) metastatic breast cancer.
AUTORES: William John Gradishar; Thomas Denis Bachelot; Stephen Saletan; Anne Marie Graham; Pedro Emanuel R Rubini Liedke; Sergio Jobim Azevedo; Virote Sriuranpong; Fatima Cardoso;
PUBLICAÇÃO: 2013, FONTE: 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 31, NÚMERO: 15
AUTORES: William John Gradishar; Thomas Denis Bachelot; Stephen Saletan; Anne Marie Graham; Pedro Emanuel R Rubini Liedke; Sergio Jobim Azevedo; Virote Sriuranpong; Fatima Cardoso;
PUBLICAÇÃO: 2013, FONTE: 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 31, NÚMERO: 15
INDEXADO EM: WOS
WOS7
TÃTULO: ALTERNATIVE (EGF114299): A study of lapatinib, trastuzumab, and endocrine therapy in patients who received neo-/adjuvant trastuzumab (IV) and endocrine therapy
AUTORES: William John Gradishar; Zsuzsanna Kahan; Janice Tsang; Constanta Timcheva; Sergei Tjulandin; Fatima Cardoso; Ruta Grigiene; Hiroji Iwata; Maccon Keane; Kristina Luebbe; Zora Neskovic Konstantinovic; Sergio D Simon; Salomon Stemmer; Damir Vrbanec; Tammy Arbani; Allison M Florance; Yingjie J Huang; Meggan Leigh; Susan Wroblewski; Stephen R D Johnston;
PUBLICAÇÃO: 2012, FONTE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 15
AUTORES: William John Gradishar; Zsuzsanna Kahan; Janice Tsang; Constanta Timcheva; Sergei Tjulandin; Fatima Cardoso; Ruta Grigiene; Hiroji Iwata; Maccon Keane; Kristina Luebbe; Zora Neskovic Konstantinovic; Sergio D Simon; Salomon Stemmer; Damir Vrbanec; Tammy Arbani; Allison M Florance; Yingjie J Huang; Meggan Leigh; Susan Wroblewski; Stephen R D Johnston;
PUBLICAÇÃO: 2012, FONTE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, NÚMERO: 15
INDEXADO EM: WOS
WOS